APA (7th ed.) Citation

KC, d. A., NT, S., J, K., JS, H., JN, H., MN, F., . . . SA, S. (2024). Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants. HGG advances, 5(1), 100242. https://doi.org/10.1016/j.xhgg.2023.100242

Chicago Style (17th ed.) Citation

KC, de Andrade, et al. "Genome-first Approach of the Prevalence and Cancer Phenotypes of Pathogenic or Likely Pathogenic Germline TP53 Variants." HGG Advances 5, no. 1 (2024): 100242. https://doi.org/10.1016/j.xhgg.2023.100242.

MLA (9th ed.) Citation

KC, de Andrade, et al. "Genome-first Approach of the Prevalence and Cancer Phenotypes of Pathogenic or Likely Pathogenic Germline TP53 Variants." HGG Advances, vol. 5, no. 1, 2024, p. 100242, https://doi.org/10.1016/j.xhgg.2023.100242.